Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
Would the presence of an SVC stent affect your decision to offer BID vs once-daily chemoradiation for SCLC?
Does the presence of an SVC stent preclude 60/40 or other BID dose escalation for SCLC?
Answer from: Radiation Oncologist at Community Practice
There is no evidence to guide the practice one way or the other. From a biological standard point, it should not.
Sign In
or
Register
to read more
30024
Related Questions
What is the role of consolidative durvalumab and prophylactic cranial irradiation in patients with stage I small cell lung cancer?
Would you offer empiric lung SBRT for two growing FDG-avid lung lesions in a patient with severe COPD on oxygen?
Under what circumstances, if any, would you wait on initiating a TKI for metastatic recurrence of a Stage III NSCLC which occurred while on consolidative durvalumab to minimize pneumonitis risk?
Would you give lung SBRT to a patient with bullous pemphigoid on the chest and torso?
Can palliative radiation be used to treat recurrent malignant pleural effusion in NSCLC?
how do you manage atypical adenomatous hyperplasia (AAH) at the margin for 2 sites of the same lobe, in a patient with multiple GGO's s/p wedge resection?
Would you offer adjuvant radiation therapy for a completely resected, node positive mucoepidermoid carcinoma of the lung?
Does receipt of chemoimmunotherapy for LS-SCLC impact your recommendation for PCI?
What target expansions do you use when treating with 60 Gy in 15 fractions for the lung?
How well does a negative non-contrast MRI of the brain exclude metastasis in a patient with squamous cell carcinoma of the lung?